As of 2025-03-21, the Relative Valuation of KemPharm Inc (KMPH) is (22.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -481.3%.
The range of the Relative Valuation is (19.67) - (22.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 20.7x | 18.5x |
| Forward P/E multiples | 13.6x - 18.8x | 18.3x |
| Fair Price | (19.67) - (22.61) | (22.15) |
| Upside | -438.6% - -489.2% | -481.3% |
| Date | P/E |